Biopharma and med-tech companies raising money in public or private financings, including: Abram, Bicara, Breezebio, Octapharma, Respiree, Trinity, Zura.
New hires and promotions in the biopharma and med-tech industries, including: Alkermes, Ascensia, Caredx, Cosmos Health, Geovax, Karoo, Rivus, Seebelife, Transpire.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aktis, Alpha Tau, Alzecure, Amphastar, Haemonetics, Immedica, Intrabio, Larimar, Macrogenics, Mirus, Regeneron, Sanofi.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Abbvie, Biomarin, Chugai, Clinect, Epredia, Dartsbio, Five Discovery, Grünenthal, Invivyd, Microtransponder, Mindpeak, Miradx, Novartis, Novo Nordisk, Oncolytics, Pfizer, PHC, Porosome, Renew, Roche, Sarepta, Sciwind, Si-Bone, Smith+Nephew, Valinor.
Clinical updates for biopharma and med tech, including data readouts and publications: Abcuro, Arcus, Cadrenal, Fulcrum, Iovance, Keenova, Kyntra, Monte Rosa, Natera, Nicox, Novo Nordisk, Palvella, Protara, Quralis, Solascure, The United Laboratories, Viiv, Vir.
Biopharma and med-tech companies raising money in public or private financings, including: Abbott, Allurion, Alveus, Brainomix, Centauri, Exact Sciences, Salspera, Slate, Tandem Diabetes.
New hires and promotions in the biopharma and med-tech industries, including: Amber, Artiva, Boston Scientific, Diality, Helus, Human Continuum, Kyverna, Portal Access, Tectonic, Therna.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Allurion, Armata, Beren, Allurion, Bracco, Cstone, Dr. Reddy’s, Eli Lilly, Guerbet, J&J, Reunion, Sandoz, Savara, Tessera, Teva, Vanda.